BULFINCH ANNOUNCES EXPANSION WITH SPINDRIFT AND MULTIPLE LIFE SCIENCE LEASES AT CHAPEL BRIDGE PARK
BOSTON, MA – August 15, 2023
An affiliate of The Bulfinch Companies, Inc. (Bulfinch), a commercial real estate and investment firm, today announces Spindrift has renewed their lease, expanding their headquarters in Newton and the firm has also signed multiple new leases and renewals with life science tenants at Chapel Bridge Park in Newton. The recent activity further strengthens Bulfinch’s growing life science and office portfolio.
Spindrift, a sparkling water beverage company made with real fruit, has recently renewed and expanded their headquarters at Chapel Bridge Park to over 20,000 SF. The renewal and expansion demonstrates Spindrift’s continued success at the property’s location. Spindrift was represented by Jared Pimm, Vice President at CBRE.
GlycoEra AG, a European based biotechnology company which focuses on transformative medicines through precision degradation of extracellular proteins, signed a lease for 4,000 SF. GlycoEra builds a high-value pipeline of medicines based on deep expertise in glycobiology and protein degradation. GlycoEra’s innovative CustomGlycan platform enables the design, engineering, and development of novel biologics for a broad range of indications. Chapel Bridge Park will be the company’s first location outside of Switzerland.
Auron Therapeutics joins Chapel Bridge Park as a new subtenant. Auron is a platform-based biotechnology company specializing in bringing effective differentiation therapies to cancer patients helping to transform treatment.
Neuropsychology & Education Services for Children & Adolescents (NESCA), one of the most well respected and recognized pediatric neuropsychology and integrative treatment practices in New England, signed a lease renewal at Chapel Bridge Park for 8,500 SF. NESCA has been a tenant at Chapel Bridge Park since 2010. The company’s Newton office provides a second location in Massachusetts in addition to multiple offices in New Hampshire as well as staff in Vermont. NESCA was represented by Allison Hoffman, Senior Advisor at Cresa Boston.
Chapel Bridge Park is a 250,000 SF R&D, Biotech, Office Campus located just minutes away from Cambridge, Watertown and the Massachusetts Turnpike with excellent access to Route 128 (I-95) and Boston/Cambridge as well as many walkable amenities. Chapel Bridge Park features mill-style brick and beam light-filled interiors with oversized ceilings and operable windows that create a unique aesthetic with modern design features.
“We are thrilled to welcome new tenants to Chapel Bridge Park and continue our relationship with existing tenants,” stated Mike Wilcox, SVP, Director of Leasing at Bulfinch. “Newton provides an ideal location for many companies and Chapel Bridge offers a unique range of suite sizes in multiple buildings, providing flexibility for tenants to grow.”
The property consists of eight buildings set within an impeccably landscaped campus providing superior on-site amenities including a full-service café, a workplace food program, an on-site mini market, indoor bicycle storage, a fitness center with private lockers and showers and free parking surrounding the campus. Set in an amenity convenient location along the Charles River, Chapel Bridge Park provides a variety of walkable retail options just five-minutes away from restaurants, coffee shops, salons and other everyday services. Existing tenants include LabShares, BioSensics LLC, Inflammasome Therapeutics, Inc., Paytronix, among others.
Current availability at Chapel Bridge Park includes up to 18,000 SF of space. Bulfinch owns and manages over 4.2M SF of properties with current life science, medical office and office space available in Needham, Weston, Wellesley and Cambridge. Please visit www.chapelbridgepark.com and www.bulfinch.com for more information.